U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C40H68O11
Molecular Weight 724.9613
Optical Activity UNSPECIFIED
Defined Stereocenters 19 / 19
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of NIGERICIN

SMILES

[H][C@@]1(C[C@H](C)[C@@]([H])(O1)[C@]2(C)CC[C@@]([H])(O2)[C@]3(C)C[C@@H](C)[C@]4(O3)O[C@]([H])(C[C@@]5([H])CC[C@H](C)[C@@]([H])(O5)[C@@H](C)C(O)=O)C[C@@H](OC)[C@H]4C)[C@@]6([H])O[C@@](O)(CO)[C@H](C)C[C@@H]6C

InChI

InChIKey=DANUORFCFTYTSZ-SJSJOXFOSA-N
InChI=1S/C40H68O11/c1-21-11-12-28(46-33(21)26(6)36(42)43)17-29-18-30(45-10)27(7)40(48-29)25(5)19-38(9,51-40)32-13-14-37(8,49-32)35-23(3)16-31(47-35)34-22(2)15-24(4)39(44,20-41)50-34/h21-35,41,44H,11-20H2,1-10H3,(H,42,43)/t21-,22-,23-,24+,25+,26+,27+,28+,29+,30+,31+,32+,33+,34-,35+,37-,38-,39-,40+/m0/s1

HIDE SMILES / InChI

Molecular Formula C40H68O11
Molecular Weight 724.9613
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 19 / 19
E/Z Centers 0
Optical Activity UNSPECIFIED

Description

Nigericin is an antibiotic derived from Streptomyces “Nig-1”. It is the potassium ionophore and H+/K+ exchanger. It is shown to be highly effective as an ionophore for Pb(2+). Thus, nigericin may be more useful than monensin in the treatment of Pb intoxication. Nigericin induced mitochondrial membrane hyperpolarization. Malignant characteristics of human glioma cells were markedly suppressed by nigericin treatment in vivo. Nigericin induces cell death and promotes the maturation and release of IL-1beta in lipopolysaccharide (LPS)-primed monocytes and macrophages. The mechanism of induction of apoptosis by nigericin is most probably to decrease intracellular pH.

Originator

Approval Year

Targets

Primary TargetPharmacologyConditionPotency

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
Unknown
Curative
Unknown
Primary
Unknown

PubMed

Sample Use Guides

In Vivo Use Guide
Mice: 4 mg/kg/day every 2 days
Route of Administration: Intraperitoneal
In Vitro Use Guide
Nigericin inhibits gram-positive bacteria at levels below 0.5 ug/ml, but levels above 60 ug/ml are required to inhibit gram-negative bacteria such as Escherichia coli. Mycobacterium smegmatis and Candida albicans are inhibited at 2 ug/ml, and fungi are inhibited at somewhat higher concentrations. The antibiotic is not active against bacteriophages at 500 ug/ml.
Substance Class Chemical
Record UNII
RRU6GY95IS
Record Status Validated (UNII)
Record Version